Loading
CP
Claritas Pharmaceuticals, Inc. Stock: price and insider trades · Canada
Claritas Pharmaceuticals, Inc.: what insiders have been doing
This page follows insider dealings at Claritas Pharmaceuticals, Inc. as filed with SEDI. The past year has been quiet: not a single insider filing for Claritas Pharmaceuticals, Inc. The previous disclosure was published on 11 October 2021.
Since 2021, the database holds no purchases and 7 sales by insiders of the company.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
8
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€119,668
7 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 11 October 2021
Declarations8 total
118,000 shares@ CA$0.271118.5% of flowCommon SharesTSXSEDI:3817024
152,500 shares@ CA$0.263923.0% of flowCommon SharesTSXSEDI:3817025
24,500 shares@ CA$0.364.9% of flowCommon SharesTSXSEDI:3817023
27,000 shares@ CA$0.46147.1% of flowCommon SharesTSXSEDI:3814174
30,500 shares@ CA$0.43867.6% of flowCommon SharesTSXSEDI:3814169
32,500 shares@ CA$0.4518.3% of flowCommon SharesTSXSEDI:3814178
119,500 shares@ CA$0.458430.5% of flowCommon SharesTSXSEDI:3814181
Common SharesTSXSEDI:3781443
8 of 8 declarations
About Claritas Pharmaceuticals, Inc.
Claritas Pharmaceuticals, Inc. is a company focused on developing innovative treatments for rare diseases. It is listed on the Toronto Stock Exchange (XTSE).
